24/7 Market News Snapshot 21 July, 2025 – Autonomix Medical, Inc. Common Stock (NASDAQ:AMIX)

July 21, 2025

DENVER, Colo., 21 July, 2025 (www.247marketnews.com) – (NASDAQ:AMIX) are discussed in this article.
Autonomix Medical, Inc. (AMIX) is generating significant attention in the financial markets, evidenced by a remarkable pre-market trading surge, which has seen its shares rise 35.83% to $2.146, up from a previous closing price of $1.580. This increase accompanies a robust trading volume of 2.61 million shares, reflecting heightened investor confidence. Technical indicators point to the potential for continued upward momentum as the stock approaches key resistance levels. Market enthusiasm surrounding AMIX may suggest positive developments or a favorable shift in investor sentiment, making it a compelling stock to monitor.

In tandem with this market activity, Autonomix Medical has announced a vital advancement in its technology portfolio with the issuance of U.S. Patent No. 12,295,646, titled “Smart Torquer and Methods for Using the Same.” This patent solidifies Autonomix’s position as a leader in precision nerve-targeted treatments by optimizing the manipulation of elongated intravascular devices used in minimally invasive procedures. The new smart torquer device incorporates advanced electronic components, enabling enhanced mechanical control and effective data communication in intravascular applications.

CEO Brad Hauser noted, “This patent represents a pivotal step in our mission to develop differentiated technologies for large and underserved markets.” The smart torquer is set to improve control and signal integration for a variety of intravascular procedures, allowing for expansion into lucrative sectors such as cardiology, neurosurgery, and interventional radiology. Autonomix’s first-in-class technology platform employs a catheter-based microchip sensing array that detects and differentiates neural signals with unprecedented sensitivity, offering solutions for chronic pain management and hypertension.

With over 80 patents granted and an additional 40 pending, Autonomix Medical is poised to transform clinical outcomes and revolutionize treatments involving the nervous system, focusing on innovation as the cornerstone of its mission.

Related news for (AMIX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.